尚无临床试验可确定一种偏头痛治疗（急性发作期治疗或预防性治疗）优于其他治疗。 一般而言，与非特异性治疗相比，首选曲普坦类。 不过，尚无直接比较曲普坦类的试验。
Associate Professor of Neurology
Department of Neurology
Duke University Medical Center
TAC was an unpaid site PI for the Alder study ALD403-CLIN-011 (monoclonal Ab against CGRP as treatment for chronic migraine), which ended in July 2017. TAC served as a paid consultant for Eli Lilly Co. in November 2016. In 2017 he served as a paid consultant for Alphasights, a global healthcare consulting organization, regarding migraine headache diagnosis and treatment. He has provided expert testimony regarding headache disorders for a legal case in 2015, and expects to be paid to provide expert testimony on headache disorders in 2018 for a legal case relating to the diagnosis, treatment, and standard of care for headache disorders.
Dr Timothy Collins would like to gratefully acknowledge Dr Ann Donnelly, the previous contributor to this monograph. AD declares that she has no competing interests.